賽凱醫(yī)藥致力于幫助中小生產(chǎn)企業(yè)開拓國(guó)際市場(chǎng)，專注于甾體激素原料藥和中間體，已在印度市場(chǎng)取得話語(yǔ)權(quán)。與多個(gè)省份企業(yè)合作，產(chǎn)品銷往歐洲、南美等地。自2019年，公司還開展原料藥進(jìn)口、注冊(cè)和代理采購(gòu)，與國(guó)外企業(yè)建立合作，助力母公司和國(guó)內(nèi)客戶。未來(lái)，賽凱醫(yī)藥將提升業(yè)務(wù)水平，打造品牌形象，整合資源，實(shí)現(xiàn)企業(yè)間的戰(zhàn)略合作，共創(chuàng)共贏。
賽凱醫(yī)藥致力于幫助中小生產(chǎn)企業(yè)開拓國(guó)際市場(chǎng)，專注于甾體激素原料藥和中間體，已在印度市場(chǎng)取得話語(yǔ)權(quán)。與多個(gè)省份企業(yè)合作，產(chǎn)品銷往歐洲、南美等地。自2019年，公司還開展原料藥進(jìn)口、注冊(cè)和代理采購(gòu)，與國(guó)外企業(yè)建立合作，助力母公司和國(guó)內(nèi)客戶。未來(lái)，賽凱醫(yī)藥將提升業(yè)務(wù)水平，打造品牌形象，整合資源，實(shí)現(xiàn)企業(yè)間的戰(zhàn)略合作，共創(chuàng)共贏。
SACHEM Pharma is committed to helping small and medium-sized manufacturers to explore the international market, focusing on steroid hormones apis and intermediates, and has gained a voice in the Indian market. With the cooperation of enterprises in many provinces, products are sold to Europe, South America and other places. Since 2019, the company has also carried out import, registration and agent procurement of apis, established cooperation with foreign enterprises, and helped the parent company and domestic customers. In the future, SACHEM Pharma will improve its business level, build its brand image, integrate resources, achieve strategic cooperation between enterprises, and create a win-win situation.
